Predictors of clinical metastasis in prostate cancer patients receiving androgen deprivation therapy: results from CaPSURE (Q84304095)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637339%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

title

Predictors of clinical metastasis in prostate cancer patients receiving androgen deprivation therapy: results from CaPSURE (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637339%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

Robert Abouassaly

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637339%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Alan Paciorek

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637339%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Charles J Ryan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637339%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Peter R Carroll

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637339%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Eric A Klein

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637339%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

publication date

1 October 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637339%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637339%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

volume

115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637339%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

issue

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637339%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

page(s)

4470-4476

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637339%20AND%20SRC:MED&resulttype=core&format=json

Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials

3 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24526

7 January 2021

Prognostic factors in metastatic and hormonally unresponsive carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24526

7 January 2021

The natural history of androgen independent prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24526

7 January 2021

Initial treatment patterns and outcome of contemporary prostate cancer patients with bone metastases at initial presentation: data from CaPSURE.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24526

7 January 2021

Prostate-specific antigen nadir and cancer-specific mortality following hormonal therapy for prostate-specific antigen failure

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24526

7 January 2021

Prostate-specific antigen doubling time before onset of chemotherapy as a predictor of survival for hormone-refractory prostate cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24526

7 January 2021

Time to prostate-specific antigen nadir after androgen suppression therapy for postoperative or postradiation PSA failure and risk of prostate cancer-specific mortality

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24526

7 January 2021

The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24526

7 January 2021

The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24526

7 January 2021

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24526

7 January 2021

Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24526

7 January 2021

Effect of young age on prostate cancer survival: a population-based assessment (United States).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24526

7 January 2021

Survival of men with clinically localized prostate cancer treated with prostatectomy, brachytherapy, or no definitive treatment: impact of age at diagnosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24526

7 January 2021

Survival in men with nonmetastatic prostate cancer treated with hormone therapy: a quantitative systematic review.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24526

7 January 2021

Identifiers

DOI

10.1002/CNCR.24526

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637339%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference